Robert Noveck
Clinical Pharmacology · Durham, NCNPI 1336330356
Payments from drug & device makers
Across 396 payments — averaging $7006.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.1M
- Boehringer Ingelheim$518K
- Janssen Research & Development, LLC$277K
- Eli Lilly$229K
- Novavax Inc$125K
- Johnson & Johnson$116K
- plus $414K from 12 others
Across 3 payments — averaging $5299.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$16K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 65 | $1,095,873 |
| Boehringer Ingelheim | 24 | $518,193 |
| Janssen Research & Development, LLC | 16 | $277,044 |
| Eli Lilly | 18 | $229,127 |
| Novavax Inc | 15 | $124,726 |
| Johnson & Johnson | 11 | $115,918 |
| Astrazeneca UK Limited | 3 | $107,214 |
| Alnylam Pharmaceuticals Inc. | 27 | $63,849 |
| GSK | 15 | $63,269 |
| Organon | 19 | $61,861 |
| Sanofi Pasteur Inc. | 7 | $35,337 |
| Lexicon Pharmaceuticals, Inc. | 9 | $20,911 |
| Currax Pharmaceuticals LLC | 14 | $19,627 |
| Boehringer Ingelheim International GmbH | 29 | $19,251 |
| Novo Nordisk AS | 121 | $11,456 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $8,200 |
| Bavarian Nordic A/s | 1 | $1,900 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $1,000 |
How this compares
Too few clinical pharmacology providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.